The purpose of this study is to investigate the long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner's syndrome.
Study Type
OBSERVATIONAL
Somatropin powder and solvent for solution for injection
Efficacy of Zomacton® treatment measured by the increase in body height per annuum
Time frame: 5 years
Efficacy of Zomacton® treatment measured by the increase in body weight per annuum
Time frame: 5 years
Safety of Zomacton® and the application device measured by local adverse reactions to the application device
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.